Stephen J Stahl

Title: The Innovations of Stephen J Stahl

Introduction

Stephen J Stahl is a notable inventor based in Bethesda, MD, who has made significant contributions to the field of biomedical research. His work primarily focuses on the development of novel therapeutic agents that target specific biological pathways. With a strong background in molecular biology, Stahl has been instrumental in advancing our understanding of hepatocyte growth factor and its implications in various medical conditions.

Latest Patents

Stahl holds a patent for a truncated hepatocyte growth factor variant protein, known as HGF/NK2. This invention relates to a novel truncated form of hepatocyte growth factor (HGF) that specifically antagonizes the activity of HGF. The patent details the purification, molecular cloning, and recombinant expression of these truncated HGF variants, as well as their potential pharmaceutical applications. The small HGF variants can either inhibit or stimulate HGF mitogenesis in cells expressing the receptor for HGF, showcasing their versatility in therapeutic contexts.

Career Highlights

Stephen J Stahl is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to collaborate with leading scientists and contribute to groundbreaking research in health and medicine. His expertise in the field has positioned him as a key figure in the development of innovative treatments.

Collaborations

Stahl has worked alongside esteemed colleagues such as Andrew M L Chan and Jeffrey S Rubin. These collaborations have fostered a rich environment for scientific inquiry and innovation, leading to advancements in understanding the role of HGF in various biological processes.

Conclusion

Stephen J Stahl's contributions to the field of biomedical research, particularly through his patent on truncated hepatocyte growth factor variants, highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the development of new therapeutic strategies.